808 filings
Page 17 of 41
4
7ma menwn4wgyfkv
12 May 15
PEREGRINE PHARMACEUTICALS / STEVEN W KING ownership change
12:00am
4
el1skm
12 May 15
PEREGRINE PHARMACEUTICALS / DAVID POHL ownership change
12:00am
4
kf7jwn6q2md01
1 May 15
PEREGRINE PHARMACEUTICALS / PAUL J LYTLE ownership change
12:00am
4
tcqbp5npj1 zgnxpob
1 May 15
PEREGRINE PHARMACEUTICALS / STEVEN W KING ownership change
12:00am
4
7nk4faq8vp5epoh5d 11
1 May 15
PEREGRINE PHARMACEUTICALS / Shelley PM Fussey ownership change
12:00am
8-K
gdrsosnw iutuo85we43
14 Apr 15
Entry into a Material Definitive Agreement
12:00am
424B5
lbrmhm8a2g8gr188gjq
13 Apr 15
Prospectus supplement for primary offering
12:00am
UPLOAD
9aojp8z6f
12 Mar 15
Letter from SEC
12:00am
8-K
b01lfnm5 pdpp
12 Mar 15
Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2015 Financial Results and Recent Developments
12:00am
8-K
c1705sue 25o
10 Mar 15
Peregrine Pharmaceuticals Declares Quarterly Dividend
12:00am
CORRESP
l21q4zgfe
3 Mar 15
Correspondence with SEC
12:00am
UPLOAD
x75y3bobzxa9d7a
24 Feb 15
Letter from SEC
12:00am
SC 13G/A
yhhfffu719g1cylhz7
13 Feb 15
Peregrine Pharmaceuticals Inc
12:00am
SC 13G/A
4khl5s uqzor2q8clb
29 Jan 15
Peregrine Pharmaceuticals Inc
12:00am
8-K
unq70xzqdac
16 Jan 15
Phase II Clinical Data of Peregrine Pharmaceuticals' Bavituximab in combination with sorafenib Presented at ASCO Gastrointestinal Cancers Symposium
12:00am
EFFECT
p7mkpb
15 Jan 15
Notice of effectiveness
12:00am
8-K
hhyj8fmqlj7 hoko
10 Dec 14
Peregrine Pharmaceuticals Reports Second Quarter Fiscal Year 2015 Financial Results and Recent Developments
12:00am